- Home
- ANEB vs CVM Comparison
ANEB vs CVM Comparison
Compare ANEB & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANEB | CVM |
|---|---|---|
| Founded | 2020 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.0M | 53.1M |
| IPO Year | 2021 | 1987 |
Fundamental Metrics
Financial Performance| Metric | ANEB | CVM |
|---|---|---|
| Price | $1.09 | $5.48 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 138.8K | 73.7K |
| Earning Date | 02-13-2026 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.90 | $1.98 |
| 52 Week High | $3.42 | $20.41 |
Technical Indicators
Market Signals| Indicator | ANEB | CVM |
|---|---|---|
| Relative Strength Index (RSI) | 26.03 | 45.14 |
| Support Level | $1.02 | $4.90 |
| Resistance Level | $1.14 | $5.95 |
| Average True Range (ATR) | 0.10 | 0.54 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 48.34 | 32.13 |
Price Performance
Historical ComparisonAbout ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.